Supplementary Table 4: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

Name: Supplementary Table 4: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
Creator: Taylor & Francis
Published: 2021-11-18T09:27:00+08:00

DataCite Commons2024-05-17 更新2025-04-15 收录

慢性疼痛药物试验

药物安全性评估

数据链接：

https://tandf.figshare.com/articles/dataset/Supplementary_Table_4_Tanezumab_for_chronic_low_back_pain_a_long-term_randomized_celecoxib-controlled_Japanese_Phase_3_safety_study/17040287 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table 4. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study Summary of TEAEs of possible decreased sympathetic function through week 80 (treatment + follow-up periods)

提供机构：

Taylor & Francis

创建时间：

2021-11-18